FDA finally approves new promising Novo Nordisk medicine

Xultophy will be ready for the US market sometime in the first half of 2017

Nov 22, 2016

It took a while, but the Danish pharmaceutical giant Novo Nordisk’s new diabetes product Xultophy has finally been approved by the US Food and Drug Administration (FDA).

Xultophy, which is a combination of two of Novo Nordisk’s new products (Victoza and Tresiba), is a product for adults with type-2 diabetes.

“We are pleased with the approval of Xultophy 100/3.6 and look forward to launching it in the US in the first half of 2017,” said Mads Krogsgaard Thomsen, the executive vice president and chief science officer of Novo Nordisk.

“We believe Xultophy 100/3.6 offers significant benefits and is an important and convenient treatment option especially for people not achieving sufficient glycaemic control with basal insulin.”

Delayed approval
The product, which was approved in Europe in 2014, is expected to be launched in the US during the first half of 2017.

A committee under the umbrella of the FDA decided unanimously in May 2016 that Xultophy should be approved, but the FDA decided to extend the approval process earlier this year.

Novo Nordisk will hope the new medication will boost its business in the US, which has suffered mightily recently due to pricing challenges in the US market.

TOP STORIES

“Talents, start using AI tools now,” says Siri and Change.org founder

In an exclusive interview with The Copenhagen Post, the founder of Siri and Change.org, and currently VP of AI Experience at Airbnb, gives young talents advice on how to deal with the job market changed by artificial intelligence.
Testing free school meals for 20,000 kids and tax deduction for homeowners in 2025 Finance Act

The government has reached an agreement on next year’s Finance Act with SF and Radikale Venstre. A test on free school meals for a limited number of children will be introduced. Homeowners will get more options for deductions for home improvements
Make your voice heard as an expat

In my last op-ed, I made the case that we, expats living in Denmark, need to step up if we want to tackle the headaches that seem baked into expat life—e.g., counterintuitive laws and endless paperwork. With almost 16% of Denmark’s population made up of internationals, we actually have the numbers to influence real change. But after publishing the last op-ed, several readers contacted me and asked: Okay, but what can we actually do?
Danish politicians will double life science exports in a few years

“Strategy for life science” is a policy agreement to support the pharmaceutical industry’s opportunities to double exports to DKK 350 billion towards 2030
Royal House unveils new portraits of King Frederik and Queen Mary

Ten months after Frederik went from crown prince to king, new civil portraits of the new royal couple have been taken.
“Without internationals, we wouldn’t have the people we need,” says Fujifilm

Fujifilm’s Hillerød facility thrives with a diverse workforce, employing over 1,800 people from more than 65 nationalities. Morten Munk, Director of Global Alliance Management, highlights how the company’s rapid growth relies on attracting international talent due to Denmark’s limited pool of scientific professionals.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

5 Dec: A guided tour of Christiansborg

Career

“Talents, start using AI tools now,” says Siri and Change.org founder

In an exclusive interview with The Copenhagen Post, the founder of Siri and Change.org, and currently VP of AI Experience at Airbnb, gives young talents advice on how to deal with the job market changed by artificial intelligence.
“Without internationals, we wouldn’t have the people we need,” says Fujifilm

Fujifilm’s Hillerød facility thrives with a diverse workforce, employing over 1,800 people from more than 65 nationalities. Morten Munk, Director of Global Alliance Management, highlights how the company’s rapid growth relies on attracting international talent due to Denmark’s limited pool of scientific professionals.
“Now the biggest challenge is to retain internationals”, says Ferring

Mads Hougaard, senior HR director at the pharmaceutical company, explains that “it is also a challenge for society itself. I think collaboration between institutions, companies, and stakeholders could be beneficial.”

Want to advertise your job with CPH Post?

Jobs